Handa Pharmaceuticals (6620)

Currency in TWD
78.70
-1.20(-1.50%)
Closed·
6620 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
77.8080.40
52 wk Range
67.30154.00
Key Statistics
Bid/Ask
34.70 / 35.10
Prev. Close
86.5
Open
79.7
Day's Range
77.8-80.4
52 wk Range
67.3-154
Volume
799.21K
Average Volume (3m)
417.18K
1-Year Change
4.5812%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6620 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
200.00
Upside
+154.13%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States. The company offers ONCORE, a proprietary drug delivery technology that was developed to improve the patient compliance and safety of the tyrosine kinase inhibitor of oncology drugs; Tascenso ODT for the treatment of multiple sclerosis; and HND-033, HND-039, and HND-027 for oncology diseases. It also provides Quetiapine XR to treat Schizophrenia; Dexlansoprazole DR capsules to treat erosive esophagitis and heartburn associated with symptomatic non-erosive gastroesophageal reflux disease; HND-004 for treating diabetes; HND-032 for smoking cessation; and HND-026, a GI drug. Handa Pharmaceuticals, Inc. was founded in 2014 and is headquartered in Tainan City, Taiwan.

Compare 6620 to Peers and Sector

Metrics to compare
6620
Peers
Sector
Relationship
P/E Ratio
17.6x0.0x−0.4x
PEG Ratio
0.400.000.00
Price/Book
2.3x0.0x2.6x
Price / LTM Sales
7.6x0.0x3.2x
Upside (Analyst Target)
-0.0%46.7%
Fair Value Upside
Unlock0.0%7.6%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 200.00
(+154.13% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.83%
Dividend Yield
1.74%
Industry Median 2.37%
Annualized payout
1.51
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 25, 2026
EPS / Forecast
1.12 / --
Revenue / Forecast
299.92M / --
EPS Revisions
Last 90 days

6620 Income Statement

FAQ

What Is the Handa Pharmas (6620) Stock Price Today?

The Handa Pharmas stock price today is 78.70 TWD.

What Stock Exchange Does Handa Pharmas Trade On?

Handa Pharmas is listed and trades on the Taipei Exchange.

What Is the Stock Symbol for Handa Pharmas?

The stock symbol for Handa Pharmas is "6620."

Does Handa Pharmas Pay Dividends? What’s The Current Dividend Yield?

The Handa Pharmas dividend yield is 1.93%.

What Is the Handa Pharmas Market Cap?

As of today, Handa Pharmas market cap is 13.23B TWD.

What Is Handa Pharmas's Earnings Per Share (TTM)?

The Handa Pharmas EPS (TTM) is 4.83.

When Is the Next Handa Pharmas Earnings Date?

Handa Pharmas will release its next earnings report on Jun 03, 2026.

From a Technical Analysis Perspective, Is 6620 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Handa Pharmas Stock Split?

Handa Pharmas has split 2 times.

What is the current trading status of Handa Pharmas (6620)?

As of Apr 24, 2026, Handa Pharmas (6620) is trading at a price of 78.70 TWD, with a previous close of 86.50 TWD. The stock has fluctuated within a day range of 77.80 TWD to 80.40 TWD, while its 52-week range spans from 67.30 TWD to 154.00 TWD.

What Is Handa Pharmas (6620) Price Target According to Analysts?

The average 12-month price target for Handa Pharmas is 200.00 TWD, with a high estimate of 200 TWD and a low estimate of 200 TWD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +154.13% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.